65 related articles for article (PubMed ID: 30093363)
1. Clinical correlates of decreased plasma coenzyme Q10 levels in patients with multiple system atrophy.
Du J; Wang T; Huang P; Cui S; Gao C; Lin Y; Fu R; Shen J; He Y; Tan Y; Chen S
Parkinsonism Relat Disord; 2018 Dec; 57():58-62. PubMed ID: 30093363
[TBL] [Abstract][Full Text] [Related]
2. Coenzyme Q10: A Biomarker in the Differential Diagnosis of Parkinsonian Syndromes.
Bartošová T; Klempíř J; Hansíková H
Antioxidants (Basel); 2023 Dec; 12(12):. PubMed ID: 38136223
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy.
Nakamoto FK; Okamoto S; Mitsui J; Sone T; Ishikawa M; Yamamoto Y; Kanegae Y; Nakatake Y; Imaizumi K; Ishiura H; Tsuji S; Okano H
Sci Rep; 2018 Sep; 8(1):14215. PubMed ID: 30242188
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: a cross-sectional and longitudinal study.
Peng L; Wan L; Liu M; Long Z; Chen D; Yuan X; Tang Z; Fu Y; Zhu S; Lei L; Wang C; Peng H; Shi Y; He L; Yuan H; Wan N; Hou X; Xia K; Li J; Chen C; Qiu R; Tang B; Chen Z; Jiang H
J Neurol; 2023 Sep; 270(9):4248-4261. PubMed ID: 37184660
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Inflammatory and Immune Landscape in Multiple System Atrophy: A Cross-Sectional Study.
Yuan X; Wan L; Chen Z; Long Z; Chen D; Liu P; Fu Y; Zhu S; Peng L; Qiu R; Tang B; Jiang H
Mov Disord; 2024 Feb; 39(2):391-399. PubMed ID: 38155513
[TBL] [Abstract][Full Text] [Related]
6. No Correlation between Plasma GPNMB Levels and Multiple System Atrophy in Chinese Cohorts.
Wan L; Fu Y; Chen Z; Long Z; Chen D; Yuan X; Zhu S; Peng L; Liu W; Qiu R; Tang B; Jiang H
Mov Disord; 2023 Oct; 38(10):1956-1961. PubMed ID: 37497669
[TBL] [Abstract][Full Text] [Related]
7. Coenzyme Q10 Status as a Determinant of Muscular Strength in Two Independent Cohorts.
Fischer A; Onur S; Niklowitz P; Menke T; Laudes M; Rimbach G; Döring F
PLoS One; 2016; 11(12):e0167124. PubMed ID: 27907044
[TBL] [Abstract][Full Text] [Related]
8. Corneal confocal microscopy may help to distinguish Multiple System Atrophy from Parkinson's disease.
Niu X; Yin P; Guan C; Shao Q; Cui G; Zan K; Xu C
NPJ Parkinsons Dis; 2024 Mar; 10(1):63. PubMed ID: 38493181
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Coenzyme Q
Ayob Alsaiegh OM; Lateef Husein A; Harith MM; Dhafer Abdulnafa Z
Arch Razi Inst; 2023 Jun; 78(3):853-861. PubMed ID: 38028821
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate is modified by tea/coffee metabolites and reversely correlated with multiple system atrophy and Parkinson's disease.
Li XY; Xue T; Lai H; Dai J; Peng F; Xu F; Zhu J; Li X; Hu J; Li W; He R; Chen L; Chen Y; Ding C; Zhao G; Chen X; Ye Q; Xu Z; Wang C
Heliyon; 2024 Mar; 10(5):e26588. PubMed ID: 38434286
[TBL] [Abstract][Full Text] [Related]
11. Validation Study of the MDS Criteria for the Diagnosis of Multiple System Atrophy in the Mayo Clinic Brain Bank.
Sekiya H; Koga S; Murakami A; Kawazoe M; Kim M; Martin NB; Uitti RJ; Cheshire WP; Wszolek ZK; Dickson DW
Neurology; 2023 Dec; 101(24):e2460-e2471. PubMed ID: 37816641
[TBL] [Abstract][Full Text] [Related]
12. The Association between the Diversity of Coenzyme Q10 Intake from Dietary Sources and the Risk of New-Onset Hypertension: A Nationwide Cohort Study.
Dai S; Tian Z; Zhao D; Liang Y; Zhong Z; Xu Y; Hou S; Yang Y
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613050
[TBL] [Abstract][Full Text] [Related]
13. Reductions in COQ2 Expression Relate to Reduced ATP Levels in Multiple System Atrophy Brain.
Hsiao JT; Purushothuman S; Jensen PH; Halliday GM; Kim WS
Front Neurosci; 2019; 13():1187. PubMed ID: 31736705
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers.
Goolla M; Cheshire WP; Ross OA; Kondru N
Front Neurol; 2023; 14():1210220. PubMed ID: 37840912
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of multiple system atrophy: A literature review.
Kaplan S
Rev Neurol (Paris); 2024 May; 180(5):438-450. PubMed ID: 38453600
[TBL] [Abstract][Full Text] [Related]
16. The characteristics and alteration of peripheral immune function in patients with multiple system atrophy.
Wang M; Yan Z; Wang J; Yang Y; Deng Q; Han Y; Zhang L; Yang H; Pan J; Wang M
Front Neurol; 2023; 14():1223076. PubMed ID: 37771450
[TBL] [Abstract][Full Text] [Related]
17. Association study between multiple system atrophy and TREM2 p.R47H.
Ogaki K; Heckman MG; Koga S; Martens YA; Labbé C; Lorenzo-Betancor O; Walton RL; Soto AI; Vargas ER; Fujioka S; Uitti RJ; van Gerpen JA; Cheshire WP; Younkin SG; Wszolek ZK; Low PA; Singer W; Bu G; Dickson DW; Ross OA
Neurol Genet; 2018 Aug; 4(4):e257. PubMed ID: 30109269
[TBL] [Abstract][Full Text] [Related]
18. Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.
Mori A; Ishikawa KI; Saiki S; Hatano T; Oji Y; Okuzumi A; Fujimaki M; Koinuma T; Ueno SI; Imamichi Y; Hattori N
PLoS One; 2019; 14(9):e0223113. PubMed ID: 31560709
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis.
Cong S; Xiang C; Wang H; Cong S
J Neurol; 2021 Aug; 268(8):2703-2712. PubMed ID: 32162061
[TBL] [Abstract][Full Text] [Related]
20. Multiple system atrophy.
Fanciulli A; Stankovic I; Krismer F; Seppi K; Levin J; Wenning GK
Int Rev Neurobiol; 2019; 149():137-192. PubMed ID: 31779811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
